MEC Company (4971) Q4 2024 earnings summary

Executive summary

• Net sales reached 18,234 million yen, up 30.1% year-over-year, with operating income at 4,562 million yen, up 83.0% year-over-year.

• Record highs achieved in both net sales and operating income for FYE12/2024.

• Overseas sales ratio was 78.5%, reflecting strong international demand, especially in Taiwan and China.

• Profit attributable to owners of parent was 2,492 million yen, down 7.1% from the previous year.

• Comprehensive income for FY2024 was 2,969 million yen, a 7.4% decrease year-over-year.

Financial highlights

• Net sales increased by 4,214 million yen year-over-year, with chemical sales up 27.0%.

• Operating income rose by 2,069 million yen (up 83.0%), supported by higher sales volumes and favorable exchange rates.

• EBITDA increased 37.4% to 5,487 million yen.

• Major product sales: CZ up 31.0%, EXE up 22.5%, SF up 19.6%, V-Bond up 11.8% year-over-year.

• Cash flows from operating activities increased to 4,200 million yen, with year-end cash and cash equivalents at 10,254 million yen.

Outlook and guidance

• FYE12/2025 forecast: net sales of 20,000 million yen (+9.7%), operating income of 5,000 million yen (+9.6%), and net income of 3,600 million yen (+57.1%).

• Basic earnings per share expected to rise to 192.26 yen in FY2025.

• Annual dividend per share forecasted at 55.0 yen.

• Medium-term plan targets 25 billion yen in sales and at least 20% operating margin by FY2027.